Abstract
The development of medical cannabis clinics has emerged in recent years to meet needs from patients and healthcare practitioners amid changing medical cannabis regulations. As more countries are approving the use of cannabinoids for medical purposes, demand for access has increased but has not yet matched medical cannabis training. In countries where robust medical cannabis programs exist, patients are still utilizing illegal markets without adequate medical supervision, and physicians still report reluctance or barriers to prescription. The clinical use of cannabinoid-based treatments requires specific training, to support the careful assessment of patients; appropriate choice of product and chemovar; precise, personalized initiation and titration process; patient education; and continuous monitoring. Consequently, a well-trained multidisciplinary team is necessary to provide best clinical practice. A leading medical cannabis clinic in North America has created a unique model of care where clinical practice interacts with cannabinoid research development. At the clinic, coordinated patient education across physicians, nurses, pharmacists, and support staff plays a pivotal role to improve patient outcomes. Additionally, the unique, high-quality clinical experience has initiated the development of continuing medical education programs and partnership with recognized academic institutions. In a multidisciplinary environment, the creation of medical cannabis educational material and resources for healthcare practitioners and patients is supported by a peer review from the team of experts. Encouraging clinicians to be more engaged, or even to provide direct medical supervision, raises the awareness about cannabinoid potential risks and benefits and builds interest for further training. A focused medical cannabis practice or clinic allows for accelerated learning and experience, as diversity of patient cases is available at a high volume. Similarly, the unique setting allows for comprehensive data collection and the development of robust clinical research programs.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Azcarate PM, Zhang AJ, Keyhani S, Steigerwald S, Ishida JH, Cohen BE. Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population. J Gen Intern Med. 2020;35:1979–86.
Lintzeris N, Mills L, Suraev A, Bravo M, Arkell T, Arnold JC, et al. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18). Harm Reduct J. 2020;17(1):37.
Glickman A, Sisti D. Prescribing medical cannabis: ethical considerations for primary care providers. J Med Ethics. 2020;46(4):227–30.
Arboleda MF, Prosk E, Cyr C, Gamaoun R, Vigano A. Medical cannabis in supportive cancer care: lessons from Canada. Support Care Cancer. 2020;28:2999–3001.
Health Canada. Canadian cannabis survey 2019 – summary. 2019. Available from: https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html.
Wheeler M, Merten JW, Gordon BT, Hamadi H. CBD (cannabidiol) product attitudes, knowledge, and use among young adults. Subst Use Misuse. 2020;55(7):1138–45.
Joypaul S, Kelly F, McMillan SS, King MA. Multi-disciplinary interventions for chronic pain involving education: a systematic review. PLoS One. 2019;14(10):e0223306.
Davy C, Bleasel J, Liu H, Tchan M, Ponniah S, Brown A. Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review. BMC Health Serv Res. 2015;15:194.
Scholl I, Zill JM, Härter M, Dirmaier J. An integrative model of patient-centeredness - a systematic review and concept analysis. PLoS One. 2014;9(9):e107828.
Abrams DI. The therapeutic effects of cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018;49:7–11.
Mahrer NE, Gold JI, Luu M, Herman PM. A cost-analysis of an interdisciplinary pediatric chronic pain clinic. J Pain. 2018;19(2):158–65.
Joypaul S, Kelly FS, King MA. Turning pain into gain: evaluation of a multidisciplinary chronic pain management program in primary care. Pain Med Malden Mass. 2019;20(5):925–33.
Reynolds HW, Sutherland EG. A systematic approach to the planning, implementation, monitoring, and evaluation of integrated health services. BMC Health Serv Res. 2013;13:168.
Zylla D, Steele G, Eklund J, Mettner J, Arneson T. Oncology clinicians and the Minnesota Medical Cannabis Program: a survey on medical cannabis practice patterns, barriers to enrollment, and educational needs. Cannabis Cannabinoid Res. 2018;3(1):195–202.
Atkinson TM, Rosenfeld BD, Sit L, Mendoza TR, Fruscione M, Lavene D, et al. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manag. 2011;41(3):558–65.
Hui D, Bruera E. The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manag. 2017;53(3):630–43.
Matter-Walstra K, Klingbiel D, Szucs T, Pestalozzi BC, Schwenkglenks M. Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied? PharmacoEconomics. 2014;32(6):591–9.
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344–64.
Russo EB. Beyond cannabis: plants and the endocannabinoid system. Trends Pharmacol Sci. 2016;37(7):594–605.
MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12–9.
Wilsey B, Atkinson JH, Marcotte TD, Grant I. The medicinal cannabis treatment agreement: providing information to chronic pain patients through a written document. Clin J Pain. 2015;31(12):1087–96.
St Pierre M, Matthews L, Walsh Z. Cannabis education needs assessment among Canadian physicians-in-training. Complement Ther Med. 2020;49:102328.
Ware MA, Ziemianski D. Medical education on cannabis and cannabinoids: perspectives, challenges, and opportunities. Clin Pharmacol Ther. 2015;97(6):548–50.
Prescriber Training Program | Santé Cannabis. Available from: https://www.santecannabis.ca/en/physicians/to-prescribe-medical-cannabis/.
Clark CS. Medical cannabis: the oncology nurse’s role in patient education about the effects of marijuana on cancer palliation. Clin J Oncol Nurs. 2018;22(1):E1–6.
Graham M, Lucas CJ, Schneider J, Martin JH, Hall W. Translational hurdles with cannabis medicines. Pharmacoepidemiol Drug Saf. 2020;29:1325–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arboleda, M.F., Prosk, E. (2021). The Model of a Medical Cannabis Clinic. In: Narouze, S.N. (eds) Cannabinoids and Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-69186-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-69186-8_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69185-1
Online ISBN: 978-3-030-69186-8
eBook Packages: MedicineMedicine (R0)